{"id":"W1967544971","doi":"10.1111/j.1749-6632.2009.04946.x","title":"The Uses of Biomarkers in Drug Development","year":2009,"lang":"en","type":"article","venue":"Annals of the New York Academy of Sciences","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":44,"is_retracted":false,"has_abstract":true,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Biomarker; Drug development; Medicine; Surrogate endpoint; Clinical trial; Drug; Drug trial; Dosing; Efficacy; Intensive care medicine; Biomarker discovery; Bioinformatics; Oncology; Pharmacology; Internal medicine; Biology; Proteomics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04929633,0.001709903,0.00196578,0.009593038,0.001234952,0.008176379,0.001502087,0.004253731,0.002730801],"category_scores_gemma":[0.09839483,0.0007857835,0.001132951,0.006430582,0.01194009,0.01111266,0.004341531,0.005988309,0.001050947],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005360461,"about_ca_system_score_gemma":0.0034815,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001857214,"about_ca_topic_score_gemma":0.0009664914,"domain_scores_codex":[0.9626067,0.02865599,0.001616344,0.001744989,0.004921763,0.0004541915],"domain_scores_gemma":[0.90338,0.07391501,0.007437935,0.006101066,0.007746637,0.001419345],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001941825,0.00007974184,0.005046975,0.001118552,0.0001664799,0.0002195662,0.0003268363,0.006584289,0.0003445176,0.6892414,0.009397818,0.2872796],"study_design_scores_gemma":[0.0000618323,0.0002488296,0.002583229,0.001922184,0.00009022761,0.0004428732,0.0002301765,0.006665745,0.0009153532,0.87388,0.1128229,0.000136636],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.009462142,0.5813136,0.243401,0.09915037,0.003677806,0.0003022575,0.0004807374,0.0003479597,0.0618641],"genre_scores_gemma":[0.3928728,0.4068252,0.1683199,0.01440474,0.007685313,0.0008973012,0.0002826389,0.0001412391,0.008570775],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.04929633,"threshold_uncertainty_score":0.260707,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4867356350806032,"score_gpt":0.4610488062307128,"score_spread":0.02568682884989043,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}